← SynDRA
Pfi-4
SynDRA canonical compound SYN0059454 — structure-anchored drug synonym record
| Clinical phase | Preclinical |
|---|
| Primary target(s) | BRPF1 |
|---|
| Mechanism of action | bromodomain inhibitor |
|---|
All known targets
Mechanisms of action (all sources)
- BRPF1 BINDER
- BET bromodomain inhibitor
- BRPF1 INHIBITOR
Cross-references
Synonyms
- GSK6853
- PFI4
- PFI 4
- CHEMBL3356143
- N-[2,3-Dihydro-1,3-dimethyl-2-oxo-6-(1-pyrrolidinyl)-1H-benzimidazol-5-yl]-2-methoxybenzamide
- N-(1,3-Dimethyl-2-oxo-6-(pyrrolidin-1-yl)-2,3-dihydro-1H-benzo[d]imidazol-5-yl)-2-methoxybenzamide
- GTPL8575
- EX-A823
- MolPort-004-921-423
- BCP23818
- ZINC6794685
- BDBM50032927
- s7906
- STL436496
- AKOS000482438
- CS-4866
- MCULE-9591292886
- PFI-4, >
- NCGC00476204-01
- HY-18664
- FT-0700502
- N-(1,3-dimethyl-2-oxo-6-pyrrolidin-1-ylbenzimidazol-5-yl)-2-methoxybenzamide
- RefChem:172299
- MFCD14744412
- orb1306909
- PFI-4?
- SCHEMBL25369084
- GLXC-07030
- ALB30537
- CCG-268406
- EBC-501077
- PFI-4, >=98% (HPLC)
- NCGC00476204-02
- AC-36028
- AS-55836
- BP-25373
- DA-66640
- F811883
Look up Pfi-4 in the interactive SynDRA portal →